In brief
The UK has announced a major study to evaluate exposure to per‑and polyfluoroalkyl substances and other pollutants among citizens, leveraging existing health survey data. Early indications point to limited health effects but highlight possible associations with raised cholesterol and lower birth weight, prompting calls for further research. Preliminary results are slated for 2027.
On Tuesday, the UK Health Security Agency (UKHSA) announced that it would launch a study to assess citizens’ exposure to a range of chemical pollutants, including the so‑called forever chemicals that are common in industrial processes and consumer goods, as well as heavy metals such as lead and arsenic.
The investigation will draw on blood and urine samples collected through the Health Survey for England, a long‑standing nationwide health assessment programme that has already been used to monitor the country’s public health trends. By analysing these samples, the agency aims to map the levels of per‑and polyfluoroalkyl substances (PFAS), metals and other chemicals in the general population.
UKHSA officials said the study is designed to identify potential links between chemical exposure and a range of health outcomes, including blood cholesterol levels and birth metrics. They note that, although preliminary evidence at present suggests that any adverse health effects are limited, there is emerging data that might connect higher PFAS levels with raised cholesterol and lower birth weight; further research is therefore required to understand the significance of these findings.
In a statement, Dr Edward Wynne‑Evans, director of radiation, chemicals, climate and environmental hazards at UKHSA, emphasised that the current evidence base does not yet enable the agency to categorise the health risks associated with different exposure thresholds. He described the study as an effort to “fill gaps” in understanding the long‑term consequences of PFAS and stated that “the evidence available to date suggests that any health effects are likely to be limited.”
The UKHSA highlighted that PFAS compounds are known for their environmental persistence, earning the nickname forever chemicals. Although the substances are widely used in applications ranging from stain‑resistant fabrics to food packaging, concerns about their potential health impacts have increased globally, sparking a surge in monitoring and research initiatives.
Internationally, the UK is collaborating with partners around the globe to share data, monitor emerging evidence and better assess potential health risks. The agency’s spokesperson said that such partnerships are vital for a comprehensive assessment of the chemical footprint across populations and for aligning safety standards.
At the time of the announcement, UKHSA made clear that it could not recommend routine blood testing for PFAS, citing insufficient evidence to determine a definitive medical action following a result. The agency intends to update its guidance as new data become available from the study.
The study’s preliminary findings are scheduled for release in 2027, providing UKHSA with a timeline to track exposure trends over the next few years and to explore the health implications of persistent chemical pollutants. The agency hopes that the forthcoming data will inform policy decisions and public health recommendations aimed at safeguarding the population from potential chemical hazards.
